Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1 1

Status

Completed 4Withdrawn 2Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 11OTHER 8OTHER_GOV 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Head & Neck 2Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Breast Neoplasms 9459Neoplasms 6577Prostatic Neoplasms 4394Colorectal Neoplasms 3964Lung Neoplasms 3633Carcinoma, Non-Small-Cell Lung 3576Pancreatic Neoplasms 2472Carcinoma, Hepatocellular 2407Leukemia, Myeloid, Acute 2261Multiple Myeloma 2115Stomach Neoplasms 2104Neoplasm Metastasis 1911Head and Neck Neoplasms 1864Ovarian Neoplasms 1770Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1728Brain Neoplasms 1696Rectal Neoplasms 1672Melanoma 1652Colonic Neoplasms 1629Leukemia 1498Uterine Cervical Neoplasms 1493Recurrence 1480Esophageal Neoplasms 1309Glioblastoma 1303Lymphoma, Non-Hodgkin 1202Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1108Urinary Bladder Neoplasms 1077Lymphoma, Follicular 1067

Interventions

Fentanyl 2Urinary Catheterization 1Patient Positioning 1Passive Cutaneous Anaphylaxis 1Morphine 1Methadone 1Infusions, Intravenous 1Gastrostomy 1Administration, Sublingual 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
OTHER × Breakthrough Pain × Clear all
NCT06790719 2025-01-24

BEACON

University of Southampton

Not yet recruiting
210 enrolled
LymphoidOther hematologic neoplasm

Cancer Pain, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Breakthrough Pain

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Seoul National University

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain

NCT01651910 2023-05-31

The Cancer Pain and Unmet Needs Study

University of Surrey

Terminated
162 enrolled

Cancer Pain, Neoplasms, Breakthrough Pain

NCT03809455 2020-04-22

FARADI

UNICANCER

Phase 2 Withdrawn

Breakthrough Pain

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms, Breakthrough Pain

NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

AHS Cancer Control Alberta

Phase 1 Completed
10 enrolled

Cancer Pain, Neoplasms, Pain, Breakthrough Pain

NCT02437929 2016-07-12

Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment

Antea Foundation

Completed
1,079 enrolled

Neoplasms, Pain, Breakthrough Pain

NCT02050503 2015-03-17

CP073

Grupo de Investigación Clínica en Oncología Radioterapia

Completed
33 enrolled
Head & NeckOther

Head and Neck Neoplasms, Mucositis, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡